Does a 13‑year‑old girl with no record of prior Haemophilus influenzae type b (Hib) or pneumococcal conjugate vaccination need catch‑up doses?

Hib Vaccine: Not Needed for a Healthy 13-Year-Old

A healthy 13-year-old with no documentation of prior Hib vaccination does NOT need catch-up Hib vaccination. Routine Hib vaccination is only recommended through age 59 months (under 5 years), and catch-up doses are not indicated for healthy children aged 5 years and older 1.

Age-Based Guidance for Hib Vaccination

The ACIP guidelines are explicit about age cutoffs for Hib vaccination:

• Children under 15 months starting vaccination: Need only a single dose if first vaccinated at 15-59 months of age 1
• Children 5 years and older: No routine Hib vaccination recommended for healthy individuals 1

The rationale is straightforward: Hib disease predominantly affects young children, particularly those under 2 years of age. By age 5, the risk of invasive Hib disease in immunocompetent individuals becomes negligible, making vaccination unnecessary 2.

Important Exceptions Requiring Hib Vaccination at Age 13

Your patient would need a single dose of Hib vaccine only if she has any of these high-risk conditions 1:

• Asplenia (functional or anatomic, including sickle cell disease)
• HIV infection
• Immunodeficiency (congenital or acquired)
• History of hematopoietic stem cell transplant
• Complement deficiency
• Receiving immunosuppressive chemotherapy or radiation

For these high-risk patients aged >59 months, a single dose of Hib conjugate vaccine is recommended 1.

---

Pneumococcal Vaccine: Depends on Risk Status

For pneumococcal vaccination, the answer is more nuanced and depends on whether your 13-year-old has risk factors.

Healthy 13-Year-Old Without Risk Factors

A healthy 13-year-old does NOT need catch-up pneumococcal conjugate vaccination if she has no documentation of prior vaccination. The routine PCV series is recommended only through age 59 months for healthy children 3.

13-Year-Old With Risk Factors

If your patient has any risk condition for invasive pneumococcal disease, she should receive pneumococcal vaccination regardless of prior vaccination history. Risk conditions include 3:

• Chronic heart disease (especially cyanotic congenital heart disease and cardiac failure)
• Chronic lung disease (including asthma treated with high-dose corticosteroids)
• Diabetes mellitus
• Cerebrospinal fluid leaks
• Cochlear implants
• Sickle cell disease or other hemoglobinopathies
• Anatomic or functional asplenia
• Immunocompromising conditions (HIV, chronic renal failure, nephrotic syndrome, leukemia, lymphoma, solid organ transplant, congenital immunodeficiency)

Vaccination Strategy for High-Risk 13-Year-Olds

For unvaccinated adolescents with risk conditions 3:

1. Administer PCV15 or PCV20 (or PCV13 if others unavailable)
2. If PCV15 is used: Follow with PPSV23 at least 8 weeks later
3. If PCV20 is used: No additional pneumococcal vaccine needed

The 2023 ACIP guidelines updated recommendations to include PCV15 as an option, and these vaccines can be used interchangeably 3.

Clinical Pitfalls to Avoid

• Don't assume all adolescents need catch-up vaccination: Age-based recommendations stop at 5 years for both vaccines in healthy children
• Don't forget to assess risk factors: The presence of even one risk condition changes the pneumococcal recommendation completely
• Don't use Hib vaccine in healthy adolescents: This wastes resources and is not evidence-based
• Document the assessment: If no risk factors are present, document that catch-up vaccination was considered but not indicated based on current guidelines

The evidence strongly supports that invasive Hib disease risk diminishes dramatically after early childhood in immunocompetent individuals 2, making routine vaccination beyond age 5 unnecessary and not cost-effective.